May 15, 2026

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

KFF Health News

May 14, 2026

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.

Conexiant

May 13, 2026

AI May Improve Breast Mitotic Scoring

Junior pathologists showed higher mitotic score accuracy and agreement with artificial intelligence assistance in a preliminary single-center reader study

Conexiant

May 12, 2026

Frozen Section in Endometrial Care?

Systematic review examines intraoperative biopsy accuracy across endometrial pathologies and diagnostic settings.

Conexiant

May 11, 2026

Folate Biomarkers Linked to Lung Cancer

Cross-sectional NHANES analysis found associations between select folate markers and self-reported physician-diagnosed lung cancer, though the direction and clinical significance of the relationship remain unclear

Conexiant

May 08, 2026

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

Conexiant

May 08, 2026

Reduced-Dose Radiation Shows Durable Control

Single-arm cohort findings contrast with interim results from NRG-HN005, underscoring ongoing uncertainty around treatment deintensification.

Conexiant

May 06, 2026

Dalbavancin Exposure Linked to Higher Success in Bacteremia

Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory

Conexiant

May 05, 2026

PET/CT and MRI Model May Help Stratify Prostate Cancer Risk

Retrospective multicenter radiomics study showed moderate to high discrimination in two small external cohorts

Conexiant

May 05, 2026

Second Primary Cancer Risk Shifts Over Time

US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups

Conexiant